Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-10

Clinical Trial Update: Treatment of Primary CNS Lymphoma ( FTD ) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for treatment of Primary CNS Lymphoma (PCNSL) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mingzhi Zhang | Conditions: Primary CNS Lymphoma (PCNSL) | Phase 2 | Status: COMPLETED